Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMaineHealth

About this trial

This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.

Eligibility criteria

Qualifiers

Aged 18 years or older

Admitted to the intensive care unit after cardiac arrest episode

Unresponsive after resuscitation

Disqualifiers

Moribund / actively dying at the time of evaluation

Informed consent cannot be obtained within 24 hours of resuscitation

Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

MaineHealth

Lead sponsor

National Institute of General Medical Sciences (NIGMS)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator